Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00747591 · ClinicalTrials.gov registry record

Urine Concentration of S100B in Extremely Premature Infants

A clinical trial, sponsored by University of Utah.

Completed
Registry status
68
Enrollment target

NCT00747591 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 68 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00747591 has completed, sponsored by University of Utah.

COMPLETED
Registry status
68 participants
Enrollment target

Study Summary

S100B, a calcium-binding protein, is found predominantly in the central nervous system (CNS) and is increased in CSF and blood after CNS injury. There are two objectives to this study. Is urine S100B concentration correlated with the serum concentration of S100B in infants born at 29-36 weeks gestation. The presence and severity of intracranial pathology on S100B concentration will be investigated. Further analysis will demonstrate if birth weight, daily fluid intake, urine output, and urine creatinine influence this relationship.

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2002-11
Est. Completion 2005-04

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT00747591

The ClinicalTrials.gov registry entry for NCT00747591 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00747591 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00747591 about?

NCT00747591 is a clinical study titled "Urine Concentration of S100B in Extremely Premature Infants". S100B, a calcium-binding protein, is found predominantly in the central nervous system (CNS) and is increased in CSF and blood after CNS injury. There are two objectives to this study. Is urine S100B concentration correlated with the serum concentration of S100B in infants born at 29-36 weeks gestat...

What is the current status of trial NCT00747591?

This trial is currently completed. The enrollment target is 68 participants. The study started on 2002-11. Estimated completion is 2005-04.

Who is sponsoring clinical trial NCT00747591?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.